JP2008526935A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526935A5
JP2008526935A5 JP2007550830A JP2007550830A JP2008526935A5 JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5 JP 2007550830 A JP2007550830 A JP 2007550830A JP 2007550830 A JP2007550830 A JP 2007550830A JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5
Authority
JP
Japan
Prior art keywords
use according
drug
intended
wound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526935A (ja
Filing date
Publication date
Priority claimed from GBGB0500643.2A external-priority patent/GB0500643D0/en
Application filed filed Critical
Publication of JP2008526935A publication Critical patent/JP2008526935A/ja
Publication of JP2008526935A5 publication Critical patent/JP2008526935A5/ja
Pending legal-status Critical Current

Links

JP2007550830A 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド Pending JP2008526935A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012165481A Division JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Publications (2)

Publication Number Publication Date
JP2008526935A JP2008526935A (ja) 2008-07-24
JP2008526935A5 true JP2008526935A5 (enExample) 2009-02-26

Family

ID=34224534

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007550830A Pending JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Country Status (7)

Country Link
US (3) US20080139478A1 (enExample)
EP (2) EP1858544B1 (enExample)
JP (2) JP2008526935A (enExample)
AU (1) AU2006205696C1 (enExample)
CA (1) CA2594798A1 (enExample)
GB (1) GB0500643D0 (enExample)
WO (1) WO2006075138A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
KR20150072458A (ko) * 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
US20140112898A1 (en) * 2011-03-31 2014-04-24 President And Fellows Of Harvard College Unique population of regulatory t cells that regulate tissue regeneration and wound healing
KR20160003651A (ko) * 2013-03-14 2016-01-11 가부시끼가이샤 쓰리디 매트릭스 위장 폐색 예방용 물질
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−10を疾病及び疾患の治療に用いる方法
WO2014204816A2 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
CA2920679A1 (en) 2013-08-30 2015-03-05 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN105848674A (zh) 2013-11-11 2016-08-10 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
CA2963989A1 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
CN107106655A (zh) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 使用白细胞介素‑10治疗疾病和病症的方法
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN107847583A (zh) 2015-05-28 2018-03-27 阿尔莫生物科技股份有限公司 用于治疗癌症的聚乙二醇化白细胞介素‑10
EP3341012B1 (en) 2015-08-25 2025-07-30 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Similar Documents

Publication Publication Date Title
JP2008526935A5 (enExample)
AU2002334886B2 (en) Methods and compositions for treating dermal lesions
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
US20030185839A1 (en) Methods and compositions for treating dermal lesions
CN102470163B (zh) 皮肤外用剂组合物
AU2002334886A1 (en) Methods and compositions for treating dermal lesions
ES2389285T3 (es) Péptidos bioactivos cortos y procedimientos para su uso
US20110160118A1 (en) Methods and compositions for treating oral and esophageal lesions
JP2005516885A5 (enExample)
JP2012500847A5 (enExample)
US7538082B2 (en) Methods and compositions for treating oral and esophageal lesions
WO1999006440A8 (en) Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
BR9607336A (pt) Composições de aminoácidos e utilidades das mesmas em nutrição clinica
TWI305778B (en) Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
WO2003018049A3 (en) Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
NO20062198L (no) Bradykinin B1 reseptorantagonister
WO2024169972A1 (en) New multi-functional oligopeptides
Bilic et al. The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice
WO2008113970A3 (en) Peptides
JP2004538320A5 (enExample)
RU2011133224A (ru) Новые фармацевтические композиции
CA2423004A1 (en) Peptide inhibitors of hiv entry
EP2205270A1 (en) Peptides based on the sequence of human lactoferrin and their use
EP2212352A1 (en) New synthetic arginine substituted peptides and their use
US8614187B2 (en) Peptides, compositions and uses thereof